GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] split one vial across Janoshik and Medutest — 95.1% and 99.3% — 42 comments in the full submission. View in context.
4.6k
c/retatrutide·submitted 2 years ago by u/dead_space_doug

[Lab] split one vial across Janoshik and Medutest — 95.1% and 99.3%

Labbranch of 7 comments

split one vial across Janoshik and Medutest — 95.1% and 99.3%. I will put the method line and the batch identifier up front because that is what makes this checkable. 95.1% and 99.3%. Those are measured, not estimated, and not rounded up in my favour. It is a triple agonist at the GLP-1, GIP and glucagon receptors.…

Read the full submission and all 42 comments →

This branch

7 comments, started 2 years ago
u/aa_analysis_andy341 points·2 years ago

Sceptical of the extrapolation. Forty-eight weeks does not tell you about seventy-two, and the curve shape is exactly what is unknown.

replysharereportpermalink
u/dead_space_dougOP182 points·2 years ago

What is the source for that figure — the published paper or a summary of it?

replysharereportpermalink
u/reflux_report79 points·2 years ago

not approved anywhere, which is the single most important fact in this board

replysharereportpermalink
u/employer_carveout66 points·2 years ago

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

replysharereportpermalink
[deleted]126 points·2 years ago

[deleted]

replysharereportpermalink
u/dead_space_dougOP55 points·2 years ago·edited

Is that the 48-week figure or an earlier readout?

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →